Home › Funds › Vitruvian Partners LLP › HNGE

Vitruvian Partners LLP position in HNGE

HINGE HEALTH INC · Technology

Vitruvian Partners LLP reported holding 450,000 shares of HNGE (HINGE HEALTH INC) in its Q3 2026 13F filing — a position valued at US$43.8M, representing 38.62% of its reported portfolio and ranking #1 among its reported holdings. Vitruvian Partners LLP has disclosed HNGE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)450.00K sh
Reported value held$43.76M
Portfolio Weight38.62%
First reportedQ2 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vitruvian Partners LLP's HNGE position evolved

Vitruvian Partners LLP first disclosed a stake in HNGE in Q2 2025 at 1,250,000 shares (US$64.7M). Across 6 filings, Vitruvian Partners LLP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 450,000 shares valued at US$43.8M — a reduction of -56,599 shares quarter over quarter.. Notable position changes include a 59% trim in Q2 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 1.25M $64.69M New
Q3 2025 1.25M $61.35M Hold
Q4 2025 1.25M $58.06M Hold
Q1 2026 1.25M $48.20M Hold
Q2 2026 506.60K $42.05M Reduce
Q3 2026 450.00K $43.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HNGE and 13F data

HNGE (HINGE HEALTH INC) is a Technology company. 100 other funds we track also report a position in HNGE — the largest reported positions include 11.2 Capital Management, LLC (US$204.6M), Deer Management Co. LLC (US$158.4M), BIT Capital GmbH (US$119.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HNGE

All HNGE fund holders →

FAQ

How long has Vitruvian Partners LLP held HNGE?

Vitruvian Partners LLP has disclosed HNGE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Vitruvian Partners LLP's current position in HNGE?

As of Q3 2026, Vitruvian Partners LLP holds 450.00K shares of HNGE (HINGE HEALTH INC), valued at $43.76M, representing 38.62% of its reported portfolio and ranking #1.

Has Vitruvian Partners LLP been buying or selling HNGE?

In the latest 13F filing (Q3 2026), Vitruvian Partners LLP reduced its position in HNGE.

Which other funds hold HNGE?

Other major institutional holders of HNGE include 11.2 Capital Management, LLC, Deer Management Co. LLC, BIT Capital GmbH, among 100 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.